CHRO: Chromocell Cash Calculated per Single Share

Chromocell - graphic logo of issuer CHRO

Chromocell Therapeutics (CHRO) is developing advanced non-opioid medications, aiming to achieve certification faster than its competitors. Patents on NaV1.7 channel blocking and strict FDA oversight protect the business from replication. Cash per share demonstrates financial autonomy, where the value of 0.19 serves as the current metric. Amidst a fierce battle for leadership, the company is developing safe alternatives to traditional analgesics.

Chromocell Therapeutics (CHRO) - Cash per Share from 02/21/2024 to 07/02/2025

Comprehensive metric breakdowns and analytics for chromocell.com (CHRO)

- cash availability and cash flow indicators:
Comprehensive company analysis:Chromocell Therapeutics Corporation (CHRO)
Flagship merchandise of Chromocell Therapeutics

Investors are seeking a sustainable foundation for valuing the Chromocell Therapeutics (CHRO) asset. The company's business model is based on developing proprietary chronic pain therapies with high margin potential. Analyzing the cash per share, we see the ratio of total liquidity to the number of securities. Growth in this metric confirms the ability to fund clinical trials without equity dilution. Stable dynamics of this metric guarantee financial viability until the product reaches commercialization.

Key competitors

Biogen Corp (BIIB) - Cash Funds Calculated per Share|Cash per Share NBIX|RGC - Cash on Hand per Share|Cash Funds per Share Axsome Therapeutics AXSM|Cash per Share ACADIA Pharmaceuticals Inc. ACAD|xenon-pharma.com - Cash per Share|Cash on Hand per Share Viking Therapeutics|SUPN: Cash per Share|Catalyst Pharmaceuticals (CPRX) - Cash per Share|Cash per Single Share DNLI|Cash Funds per Single Share HRMY (Harmony Biosciences Holdings, Inc.)|Cash Funds per Share Biohaven Ltd. (BHVN)|Cash Calculated per Single Share AMLX|Cash Funds per Share trevitherapeutics.com TRVI|PRAX - Cash per Single Share|Anavex Life Sciences Corp - Cash per Share|Cash on Hand per Share CeriBell Corp|Prothena Corporation PLC (PRTA) - Cash Funds per Share|Alector Therapeutics - Amount of Cash per Share|Cash Funds per Share Annexon Biosciences|Cash on Hand per Share omeros.com OMER|Cash Funds per Share Neurogene (NGNE)|Cash Funds Calculated per Share AC Immune S.A.|Cash per Share VYGR (Voyager Therapeutics Inc)|Amount of Cash per Share NMRA|scilexholding.com - Cash per Share|TVGN (tevogen.com) - Cash Funds per Single Share|ACOG: Cash per Share|CGTX: Cash Calculated per Single Share|Cash Funds per Share Inhibikase Therapeutics|Cash Funds per Single Share SAVA (Cassava)|Cash Funds per Share Assertio Therapeutics (ASRT)|Coya Therapeutics - Cash Funds per Single Share|VistaGen Therapeutics, Inc. - Cash per Single Share|ovidrx.com (OVID) - Cash on Hand per Share|ABOS: Cash per Single Share|Cash on Hand per Share CervoMed Inc|alteritytherapeutics.com (ATHE) - Cash Funds per Share|Cash per Single Share Clene Nanomedicine|Cash per Single Share PEPG|Cash on Hand per Share Jupiter Neurosciences JUNS|Cash Funds per Share Relmada (RLMD)|Cash Funds Calculated per Share Annovis Bio, Inc.|Cash per Share GRCE (Grace Tx)|Firefly Neuroscience, Inc (AIFF) - Cash on Hand per Share|KLTO - Cash Funds per Share|Cash on Hand per Share NeuroSense Therapeutics Ltd|RVPH: Cash per Share|MetaVia, Inc. (MTVA) - Cash per Share|Cash Funds per Share NeurAxis|Cash per Share heliusmedical.com|Cash per Single Share PASG (Passage Bio Inc.)|Neuphoria Therapeutics - Cash Funds per Single Share|Minerva Neurosciences Corp - Cash per Single Share|Amount of Cash per Share ATHA|ADXN - Cash Funds per Share|Cash on Hand per Share Alzamend Neuro Inc.|Cyclerion Therapeutics (CYCN) - Cash Funds per Share|Cash Funds per Single Share PTIX|KTTA (pasitheaclinics.com) - Cash per Share|CRGT (cortigent.com) - Cash Calculated per Single Share|Cash per Share ATXI|Cash Funds per Share BCLI (Brainstorm Cell)|Cash per Share CARA (Cara Therapeutics Inc)|Cash Funds Calculated per Share Eliem (ELYM)|ITCI: Cash per Single Share|Amount of Cash per Share LBPH (Longboard)|marinuspharma.com (MRNS) - Cash Funds per Share|NKGN - Cash Funds Calculated per Share|NRBO (neurobopharma.com) - Cash per Share|Sage Therapeutics (SAGE) - Cash Funds Calculated per Share|Cash per Single Share SNPX (Synaptogenix, Inc.)|TRVN - Cash on Hand per Share|Cash per Share VIGL (Vigil Neuro)|WENA: Cash Funds per Single Share|CERE - Cash Funds per Share